The ISoP Standards and Best Practices Committee.
The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is to provide best practices and recommendations for standard pharmacometric analyses-e.g., population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response, disease models-with the goal of increasing consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. We present the progress and plans of the committee and call for volunteers to start new initiatives.
Pharsight Consulting Services, Pharsight-a Certara Company, Marseille, France.
R
R
Bruno
Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM and University Paris Diderot, Paris, France.
F
F
Mentré
Astellas Pharma Global Development, Northbrook, Illinois, USA.
S
S
Tannenbaum
Division of Pharmacometrics, Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, Maryland, USA.
Y
Y
Wang
Pfizer Global Research, Groton, Connecticut, USA.
B
B
Corrigan
University at Buffalo, State University of New York, Buffalo, New York, USA.
D E
DE
Mager
D017408:Guidelines as Topic; D015233:Models, Statistical; D010599:Pharmacokinetics; D010600:Pharmacology / Q000592:standards* / Q000706:statistics & numerical data*; D011153:Population